Weekly round up from Life Sciences Industry.
MyMD Pharmaceuticals, Inc. (“MyMD”) and Akers Biosciences, Inc. (“Akers”) (NASDAQ: AKER) jointly announced a definitive merger agreement last week. The companies plan to hold a video conference for investors on Wednesday, November 18, 2020 at 4:15 p.m. ET to provide additional context on the integrated company, the clinical pipeline and drug development plan, and the commercial potential of the targeted indications.
Source: Biospace
Sign up for DistilINFO e-Newsletters.
Atlantic Healthcare plc Acquires Global Rights to Renzapride for the Treatment of Gastrointestinal Motility Disorders
Owkin Lands $25M for AI-powered Research Platform, Braid Health Scores $9M for Teleradiology and More Digital Health Funding
Market Insights of Aseptic Packaging for the Pharmaceutical Market By Top Leading Players, Key Strategies & Market Dynamics Forces
Virtual Care Company Recuro Health Raises $47 Million.
The Pursuit of a 10x Better Value-Based Care Enablement Solution and the Rise of Primary Care Physician Management Platforms
CitiusTech Acquires SDLC Partners to Drive Health Plan Digital Transformation
Top 5 RCM Challenges for Healthcare Executives in the COVID-19 Era and Beyond
Highmark Health Reaches $26 Billion in Revenue